Cui, S., Chen, S., Li, X., Liu, S. & Wang, F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 18, 1421–1424 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020).

CAS  PubMed  Article  Google Scholar 

Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054–1062 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Nahum, J. et al. Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19). JAMA Netw. Open 3, e2010478 (2020).

PubMed  PubMed Central  Article  Google Scholar 

Goshua, G. et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 7, e575–e582 (2020).

PubMed  PubMed Central  Article  Google Scholar 

Iba, T., Warkentin, T. E., Thachil, J., Levi, M. & Levy, J. H. Proposal of the definition for COVID-19-associated coagulopathy. J. Clin. Med. https://doi.org/10.3390/jcm10020191 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Trimaille, A. & Bonnet, G. [COVID-19 and venous thromboembolism] [French]. Ann. Cardiol. Angeiol. 69, 370–375 (2020).

CAS  Article  Google Scholar 

Nicolai, L. et al. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation 142, 1176–1189 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhang, C. et al. Incidence of venous thromboembolism in hospitalized coronavirus disease 2019 patients: a systematic review and meta-analysis. Front. Cardiovasc. Med. 7, 151 (2020).

PubMed  PubMed Central  Article  CAS  Google Scholar 

Zhang, L. et al. Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China: prevalence, risk factors, and outcome. Circulation 142, 114–128 (2020).

PubMed  Article  CAS  Google Scholar 

Wichmann, D. et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann. Intern. Med. 173, 268–277 (2020).

PubMed  Article  Google Scholar 

Tang, N., Li, D., Wang, X. & Sun, Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 18, 844–847 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ali, N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J. Med. Virol. 92, 2409–2411 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Agrati, C. et al. Elevated P-selectin in severe COVID-19: considerations for therapeutic options. Mediterr. J. Hematol. Infect. Dis. 13, e2021016 (2021).

PubMed  PubMed Central  Article  Google Scholar 

Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507–513 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Connors, J. M. et al. Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial. JAMA 326, 1703–1712 (2021).

CAS  PubMed  Article  Google Scholar 

Bouck, E. G. et al. COVID-19 and sepsis are associated with different abnormalities in plasma procoagulant and fibrinolytic activity. Arterioscler. Thromb. Vasc. Biol. 41, 401–414 (2021).

CAS  PubMed  Google Scholar 

Campbell, R. A. et al. Comparison of the coagulopathies associated with COVID-19 and sepsis. Res. Pract. Thromb. Haemost. 5, e12525 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bonaventura, A. et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 21, 319–329 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ackermann, M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N. Engl. J. Med. 383, 120–128 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Connors, J. M. & Levy, J. H. COVID-19 and its implications for thrombosis and anticoagulation. Blood 135, 2033–2040 (2020).

CAS  PubMed  Article  Google Scholar 

Connors, J. M. & Levy, J. H. Thromboinflammation and the hypercoagulability of COVID-19. J. Thromb. Haemost. 18, 1559–1561 (2020).

CAS  PubMed  Article  Google Scholar 

Engelmann, B. & Massberg, S. Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 13, 34–45 (2013).

CAS  PubMed  Article  Google Scholar 

Middleton, E. A. et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136, 1169–1179 (2020).

CAS  PubMed  Article  Google Scholar 

Skendros, P. et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J. Clin. Invest. https://doi.org/10.1172/JCI141374 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Mandel, J., Casari, M., Stepanyan, M., Martyanov, A. & Deppermann, C. Beyond hemostasis: platelet innate immune interactions and thromboinflammation. Int. J. Mol. Sci. https://doi.org/10.3390/ijms23073868 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Purcell, S. C. & Godula, K. Synthetic glycoscapes: addressing the structural and functional complexity of the glycocalyx. Interface Focus. 9, 20180080 (2019).

PubMed  PubMed Central  Article  Google Scholar 

Teuwen, L. A., Geldhof, V., Pasut, A. & Carmeliet, P. COVID-19: the vasculature unleashed. Nat. Rev. Immunol. 20, 389–391 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Evans, P. C. et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc. Res. 116, 2177–2184 (2020).

CAS  PubMed  Article  Google Scholar 

Nagashima, S. et al. Endothelial dysfunction and thrombosis in patients with COVID-19-brief report. Arterioscler. Thromb. Vasc. Biol. 40, 2404–2407 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Renzi, S., Landoni, G., Zangrillo, A. & Ciceri, F. MicroCLOTS pathophysiology in COVID 19. Korean J. Intern. Med. https://doi.org/10.3904/kjim.2020.336 (2020).

Article  PubMed  Google Scholar 

Varga, Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 395, 1417–1418 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

McCracken, I. R. et al. Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells. Circulation 143, 865–868 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Goldsmith, C. S., Miller, S. E., Martines, R. B., Bullock, H. A. & Zaki, S. R. Electron microscopy of SARS-CoV-2: a challenging task. Lancet 395, e99 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Nicosia, R. F., Ligresti, G., Caporarello, N., Akilesh, S. & Ribatti, D. COVID-19 vasculopathy: mounting evidence for an indirect mechanism of endothelial injury. Am. J. Pathol. 191, 1374–1384 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280.e8 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Glowacka, I. et al. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J. Virol. 84, 1198–1205 (2010).

CAS  PubMed  Article  Google Scholar 

Wang, H. et al. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res. 18, 290–301 (2008).

CAS  PubMed